THÔNG TIN TÀI LIỆU
obstructive cardiomyopathy: implications for concomitant valve procedures J Am Coll Cardiol 2016;68(14):1497–1504 241 Yu EH, Omran AS, Wigle ED, et al Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy J Am Coll Cardiol 2000;36(7):2219–2225 242 Khairy P, Van Hare GF, Balaji S, et al PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the pediatric and congenital electrophysiology society (PACES) and the heart rhythm society (HRS) Endorsed by the governing bodies of PACES, HRS, the American college of cardiology (ACC), the American heart association (AHA), the European heart rhythm association (EHRA), the Canadian heart rhythm society (CHRS), and the international society for adult congenital heart disease (ISACHD) Heart Rhythm 2014;11(10):e102–e165 243 Kwon DH, Setser RM, Popovic ZB, et al Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study Int J Cardiovasc Imaging 2008;24(6):617–625 244 Kwon DH, Smedira NG, Rodriguez ER, et al Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia J Am Coll Cardiol 2009;54(3):242–249 245 Leonardi S, Raineri C, De Ferrari GM, et al Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy Eur Heart J 2009;30(16):2003–2010 246 Fluechter S, Kuschyk J, Wolpert C, et al Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 2010;12:30 247 Frenneaux MP, Porter A, Caforio AL, et al Determinants of exercise capacity in hypertrophic cardiomyopathy J Am Coll Cardiol 1989;13(7):1521–1526 248 Finocchiaro G, Haddad F, Knowles JW, et al Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy: a potential role for comprehensive noninvasive hemodynamic assessment JACC Heart Fail 2015;3(5):408– 418 249 Coats CJ, Rantell K, Bartnik A, et al Cardiopulmonary exercise testing and prognosis in hypertrophic cardiomyopathy Circ Heart Fail 2015;8(6):1022–1031 250 Sadoul N, Prasad K, Elliott PM, et al Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy Circulation 1997;96(9):2987–2991 251 Olivotto I, Maron BJ, Montereggi A, et al Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy J Am Coll Cardiol 1999;33(7):2044–2051 252 Ostman-Smith I, Wettrell G, Riesenfeld T A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment J Am Coll Cardiol 1999;34(6):1813– 1822 253 Robertson CE, Miller HC Extreme tachycardia complicating the use of disopyramide in atrial
Ngày đăng: 22/10/2022, 12:49
Xem thêm: